EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score

Chaoting Zhang, Shance Li, Luyan Shen, Xia Teng, Yefei Xiao, Wenjun Yang, Zheming Lu

Cancer Immunology, Immunotherapy · 10.05.2024 · 73 (7)

DOI: 10.1007/s00262-024-03710-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 10.05.2024. Verfasst von Chaoting Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Biochemistry and Molecular Biology, Peking…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Receptors, Antigen, T-Cell, Lymphocyte Activation, Single-Cell Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Nova Program, Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation, Technology special fund of Hainan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptively transferred T cell receptor-engineered T cells are a promising cancer treatment strategy, and the identification of tumour-specific TCRs is essential. Previous studies reported that tumour-reactive T cells and TCRs could be isolated based on the expression of activation markers. However, since T cells with different cell states could not respond uniformly to activation but show a heterogeneous expression profile of activation and effector molecules, isolation of tumour-reactive T cells based on single activation or effector molecules could result in the absence of tumour-reactive T cells; thus, combinations of multiple activation and effector molecules could improve the efficiency of isolating tumour-specific TCRs. We enrolled two patients with lung adenocarcinoma and obtained their tumour infiltrating lymphocytes (TILs) and autologous tumour cells (ATCs). TILs were cocultured with the corresponding ATCs for 12 h and subjected to single-cell RNA sequencing. First, we identified three TCRs with the highest expression levels of IFNG and TNFRSF9 mRNA for each patient, yet only the top one or two recognized the corresponding ATCs in each patient. Next, we defined the activation score based on normalized expression levels of IFNG, IL2, TNF, IL2RA, CD69, TNFRSF9, GZMB, GZMA, GZMK, and PRF1 mRNA for each T cell and then identified three TCRs with the highest activation score for each patient. We found that all three TCRs in each patient could specifically identify corresponding ATCs. In conclusion, we established an efficient approach to isolate tumour-reactive TCRs based on combinations of multiple activation and effector molecules through single-cell RNA sequencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingReceptors, Antigen, T-CellLymphocyte ActivationSingle-Cell AnalysisLung NeoplasmsHumansAdenocarcinoma of Lung

Stichwörter der Autor:innen

Single-cell RNA sequencingT cell receptorTumour infiltrating lymphocytes

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • The Department of Pathology, the First Affiliated Hospital, Hainan Medical University, Haikou, 570102, China. ywj007@yeah.net.
  • Key Laboratory of Tropical Translational Medicine of Ministry of Education, School of Basic Medicine and Life Sciences, Hainan Medical University, Haikou, 571199, China. ywj007@yeah.net.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, 100142, China. luzhe…

Förderung

  • Beijing Nova Program
  • Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation
  • Technology special fund of Hainan Province
  • Natural Science Foundation of China
  • Peking University Medicine Sailing Program for Young Scholars’ Scientific & Technological Innovation

Zitieren

APA

Zhang, C., Li, S., Shen, L., Teng, X., Xiao, Y., Yang, W., & Lu, Z. (2024). Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score. Cancer Immunology, Immunotherapy, 73(7). https://doi.org/10.1007/s00262-024-03710-9

Vancouver

Zhang C, Li S, Shen L, Teng X, Xiao Y, Yang W, et al. Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score. Cancer Immunology, Immunotherapy. 2024;73(7). doi:10.1007/s00262-024-03710-9

BibTeX
@article{Zhang2024,
  author = {Zhang, Chaoting and Li, Shance and Shen, Luyan and Teng, Xia and Xiao, Yefei and Yang, Wenjun and Lu, Zheming},
  title = {Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  volume = {73},
  number = {7},
  doi = {10.1007/s00262-024-03710-9}
}
Kostenlos starten →